The same study also discovered defects in ER-associated protein degradation (ERAD) implicated in neurodevelopmental disorder, adaptive immunity and tumor resistance, not only did not impede, but rather enhanced GRP78 translocation into the nucleus. The gene discussed is HSPA5; the disease is neoplasm.